Log in

NYSE:CVD - Covance Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covance Inc is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
CUSIP22281610
Phone+1-609-4524440

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CVD News and Ratings via Email

Sign-up to receive the latest news and ratings for CVD and its competitors with MarketBeat's FREE daily newsletter.


Covance (NYSE:CVD) Frequently Asked Questions

What is Covance's stock symbol?

Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD."

How were Covance's earnings last quarter?

Covance Inc. (NYSE:CVD) released its quarterly earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share for the quarter, hitting analysts' consensus estimates of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analyst estimates of $631.30 million. View Covance's Earnings History.

Has Covance been receiving favorable news coverage?

Media coverage about CVD stock has been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Covance earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news headlines about the healthcare company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Covance.

Who are some of Covance's key competitors?

What other stocks do shareholders of Covance own?

What is Covance's official website?

The official website for Covance is http://www.covance.com/.

How can I contact Covance?

Covance's mailing address is 210 Carnegie Ctr, PRINCETON, NJ 08540-6233, United States. The healthcare company can be reached via phone at +1-609-4524440.


MarketBeat Community Rating for Covance (NYSE CVD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  260 (Vote Outperform)
Underperform Votes:  301 (Vote Underperform)
Total Votes:  561
MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe CVD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: Hang Seng Index (HSI)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel